Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA)

Clinical trial NCT04321031 · COMPLETED

Trial details

NCT number: NCT04321031
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Nonalcoholic Fatty Liver Disease Nonalcoholic Steatohepatitis With Liver Fibrosis

Start date: 2020-06-15
Primary completion: 2024-01-23
Enrollment: 256

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.